Cystic Fibrosis Therapeutics Market Growth, Trends And Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players - Vertex Pharmaceuticals, F. Hoffmann-La Roche, AbbVie

The global Cystic Fibrosis Therapeutics Market size is projected to accrue voluminously by 2027 registering a phenomenal CAGR of 9.5% during the review period (2022 to 2027)

Cystic Fibrosis Therapeutics Market Overview

Cystic fibrosis is a hereditary disorder, which manly affects lungs and other body parts such as pancreas, liver, and kidney. It is caused by the mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. This gene is located in chromosome number 7, and is responsible for the regulation of sweat, mucus, and body secretions. But, mutation of this gene leads to absence of CFTR activity, which in turn results in loss of chloride and alters the protein structure. Patients experience trouble in breathing, mucus formation, fatty stool, and difficulty in the passageway of the pancreas, bile duct, intestine, & salivary gland. Cystic fibrosis is diagnosed by the use of sweat test and genetic testing. Physical therapy is used for the treatment of cystic fibrosis that helps in the reduction of mucus formation and fights against infections of an organ. In addition, treatment of cystic fibrosis includes the use of drugs such as Pulmozyme, Kalydeco, and others. These drugs can be administered to the patient by different routes such as oral and by inhalation. The rising number of potential clinical pipeline candidates is one of the key factors expected to propel the market growth. Moreover, upsurge in the number of clinical trials to expand its target patient base with the existing drug portfolio is also amongst some of the drivers of this market.

Industry News

April 2019, the US Food and Drug Administration (FDA) approved Vertex Pharmaceuticals Incorporated’s KALYDECO (ivacaftor) with an aim of expanding the range of treatment options for the millions of children living with cystic fibrosis (CF).

In October 2020, Roche announced the partnership with AbbVie and acquired TMEM16A potentiators portfolio, for the treatment of cystic fibrosis patients irrespective of CFTR genotype and other respiratory illnesses. The partnership helped the firm to influence their product portfolio growth.

What are the major Applications, Types and Regions for  Cystic Fibrosis Therapeutics Market?

By Type, it is segmented into

• CFTR


• Mucolytics


• PERT


• Anti-infectives


• Bronchodilators


• Others

By Applications it is segmented into

• Hospitals


• Clinics


• Others

Cystic Fibrosis Therapeutics Market Regional Analysis

North America is at the forefront of growing in the region and is also an important revenue contributor in the global arena. Heightened awareness of disease remittance therapies among patients, rising prevalence of CF, and high public and private healthcare spending are stimulating the growth of the region. The United States has most of the people affected with CF who are of Caucasian descent. The Asia-Pacific is likely to witness the fastest progress throughout the forecast period. The growing adoption of the urban lifestyle is leading to expanding the base of patients in the region.

North America

• 
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East & Africa
  
  
  • Latin America
  
  
  
  

The Cystic Fibrosis Therapeutics Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Cystic Fibrosis Therapeutics Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

What is our  Cystic Fibrosis Therapeutics Market Report Scope?

Key Takeaways from this  Cystic Fibrosis Therapeutics Report

• Evaluate  Cystic Fibrosis Therapeutics market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.


• Understand the different dynamics influencing the market - growth driving factors, specific challenges and hidden opportunities.


• Get in-depth insights on your competitor performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis and more.


• Analyze the sales and distribution channels across geographies to enhance top-line revenues.


• Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies in your processes.


• Get a quick outlook on the  Cystic Fibrosis Therapeutics market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.


• Evaluate the import-export statistics, supply-demand and competitive landscape for more than top 20 countries globally for the market.

FAQ -

What is the study period of this market?

The Cystic Fibrosis Therapeutics Market is studied from 2017 - 2027.

 What is the growth rate of Cystic Fibrosis Therapeutics Market?

The Cystic Fibrosis Therapeutics Market is growing at a CAGR of 9.5% over the next 5 years.

What regions does this Cystic Fibrosis Therapeutics Market report covers?

North America (the United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, and Italy)

Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)

South America (Brazil, Argentina, Colombia, etc.)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.